KORU Medical Systems, Inc.
NASDAQ Capital MarketTotal Valuation
KORU Medical Systems, Inc. carries a market capitalization of 210.37M, placing it among publicly traded companies globally. Its enterprise value stands at 194.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 210.37M |
| Enterprise Value | 194.47M |
Share Statistics
KORU Medical Systems, Inc. currently has 46.13M shares outstanding.
| Shares Outstanding | 46.13M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 4.62, and the price-to-book ratio stands at -6.18.
| PE Ratio | N/A |
| PS Ratio | 4.62 |
| PB Ratio | -6.18 |
| P/TBV Ratio | 12.33 |
| P/FCF Ratio | 152.10 |
| P/OCF Ratio | 279.72 |
Enterprise Valuation
| EV / Sales | 4.50 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 147.99 |
Financial Position
KORU Medical Systems, Inc. maintains a current ratio of 2.33, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.33 |
| Quick Ratio | 1.70 |
| Debt / Equity | 19.89 |
| Debt / EBITDA | -1.87 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -8.17 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.25 |
Taxes
| Income Tax | 21,890.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
KORU Medical Systems, Inc.'s stock has gained approximately 24.79564% over the past 52 weeks. The 50-day moving average sits at 4.08, while the 200-day moving average is 4.58.
| Beta (5Y) | N/A |
| 52-Week Price Change | 24.79564% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 4.58 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, KORU Medical Systems, Inc. generated 43.26M in revenue and converted that into -2.28M in net income, yielding earnings per share of -0.05. EBITDA reached -1.80M, while operating income came in at -2.59M.
| Revenue | 43.26M |
| Gross Profit | 26.79M |
| Operating Income | -2.59M |
| Pretax Income | -2.26M |
| Net Income | -2.28M |
| EBITDA | -1.80M |
| EBIT | -2.59M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
KORU Medical Systems, Inc. holds 8.77M in cash and equivalents against 3.37M in total debt, resulting in a net debt position of -8.77M. Total book value stands at -32.32M, with working capital of 11.74M providing operational flexibility.
| Cash & Cash Equivalents | 8.77M |
| Total Debt | 3.37M |
| Net Debt | -8.77M |
| Equity (Book Value) | -32.32M |
| Book Value Per Share | -0.70 |
| Working Capital | 11.74M |
Cash Flow
KORU Medical Systems, Inc. produced 714,535.00 in operating cash flow over the past twelve months. After subtracting -599,537.00 in capital expenditures, free cash flow totaled 114,998.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 714,535.00 |
| Capital Expenditures | -599,537.00 |
| Free Cash Flow | 114,998.00 |
| FCF Per Share | 0.00 |
Margins
KORU Medical Systems, Inc. operates with a gross margin of 61.93, reflecting its pricing power and cost economics. The operating margin of -5.99 and net profit margin of -5.27 provide insight into operational efficiency.
| Gross Margin | 61.93 |
| Operating Margin | -5.99 |
| Pretax Margin | -5.22 |
| Profit Margin | -5.27 |
| EBITDA Margin | -4.17 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.04 |
| FCF Yield | 0.66 |
Scores
KORU Medical Systems, Inc. posts an Altman Z-Score of 10.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.38 |